From BLISS to ILLUMINATE studies: "Blys repetita placent"?

Ann Rheum Dis. 2016 Feb;75(2):e10. doi: 10.1136/annrheumdis-2015-208702. Epub 2015 Oct 20.

Authors

Laurent Chiche¹, Noémie Jourde-Chiche², Frederique Retornaz¹, Divi Cornec³

Affiliations

¹ Department of Internal Medicine, Hôpital Européen, Marseille, France.
² Department of Nephrology, Aix-Marseille University, AP-HM, Hôpital Conception, UMR_S 1076, Vascular Research Center of Marseille, Marseille, France.
³ Service de Rhumatologie, CHRU Brest, and EA2216, INSERM ESPRI, ERI29, Université de Brest, Brest, France.

PMID: 26487652
DOI: 10.1136/annrheumdis-2015-208702

No abstract available

Keywords: Disease Activity; Systemic Lupus Erythematosus; Treatment.

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal / administration & dosage*
B-Cell Activating Factor / antagonists & inhibitors*
Female
Humans
Lupus Erythematosus, Systemic / drug therapy*
Male

Substances

Antibodies, Monoclonal
B-Cell Activating Factor